Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
复制标题
DOI：
10.15585/mmwr.rr6702a1
复制
发表时间：
2018-04-27
期刊：
影响因子：
--
通讯作者：
Clark TA
中科院分区：
文献类型：
--
作者：
Liang JL;Tiwari T;Moro P;Messonnier NE;Reingold A;Sawyer M;Clark TA
这份报告汇编和总结了美国疾病控制与预防中心免疫实践咨询委员会(ACIP)关于预防和控制破伤风、白喉和百日咳的所有建议。作为以前发表的建议的全面摘要，本报告不包含任何新的建议，并取代了以前发表的所有报告和政策说明；本报告旨在供临床医生和公共卫生提供者作为资源使用。ACIP建议常规接种破伤风、白喉和百日咳疫苗。建议婴幼儿接种5剂系列白喉、破伤风类毒素和无细胞百日咳(DTaP)疫苗，其中包括一剂青少年增强剂量的破伤风类毒素、减量白喉类毒素和无细胞百日咳(Tdap)疫苗。从未接受过Tdap的成年人也被建议接受加强剂量的Tdap。建议妇女在每次怀孕期间服用一剂Tdap，应在怀孕27周至36周期间给予，无论以前是否接受过Tdap。在接种Tdap后，建议青少年和成年人每10年接种一次破伤风和白喉类毒素(TD)加强疫苗，以确保持续预防破伤风和白喉。
This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previously published recommendations, this report does not contain any new recommendations and replaces all previously published reports and policy notes; it is intended for use by clinicians and public health providers as a resource. ACIP recommends routine vaccination for tetanus, diphtheria, and pertussis. Infants and young children are recommended to receive a 5-dose series of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines, with one adolescent booster dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Adults who have never received Tdap also are recommended to receive a booster dose of Tdap. Women are recommended to receive a dose of Tdap during each pregnancy, which should be administered from 27 through 36 weeks’ gestation, regardless of previous receipt of Tdap. After receipt of Tdap, adolescents and adults are recommended to receive a booster tetanus and diphtheria toxoids (Td) vaccine every 10 years to assure ongoing protection against tetanus and diphtheria.